I do not see any mentioning of Leronlimab in the "
Post# of 148326
The only exception is Oregon.Health. In the April newsletter they mention Leronlimab.
https://www.ohsu.edu/sites/default/files/2020...letter.pdf
And then you see immediately the problem, a crowded area to do studies.
gf